Agilon Health (AGL) Competitors $1.14 +0.06 (+5.09%) Closing price 10/3/2025 03:59 PM EasternExtended Trading$1.11 -0.02 (-2.11%) As of 10/3/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AGL vs. GRAL, VRDN, TDOC, OMDA, AHCO, PNTG, CDNA, FTRE, FLGT, and CSTLShould you be buying Agilon Health stock or one of its competitors? The main competitors of Agilon Health include GRAIL (GRAL), Viridian Therapeutics (VRDN), Teladoc Health (TDOC), Omada Health (OMDA), AdaptHealth (AHCO), The Pennant Group (PNTG), CareDx (CDNA), Fortrea (FTRE), Fulgent Genetics (FLGT), and Castle Biosciences (CSTL). These companies are all part of the "healthcare" industry. Agilon Health vs. Its Competitors GRAIL Viridian Therapeutics Teladoc Health Omada Health AdaptHealth The Pennant Group CareDx Fortrea Fulgent Genetics Castle Biosciences Agilon Health (NYSE:AGL) and GRAIL (NASDAQ:GRAL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, media sentiment, profitability and earnings. Do analysts rate AGL or GRAL? Agilon Health presently has a consensus target price of $3.08, indicating a potential upside of 171.09%. GRAIL has a consensus target price of $56.67, indicating a potential downside of 13.54%. Given Agilon Health's stronger consensus rating and higher possible upside, research analysts clearly believe Agilon Health is more favorable than GRAIL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilon Health 2 Sell rating(s) 12 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.11GRAIL 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has stronger valuation & earnings, AGL or GRAL? Agilon Health has higher revenue and earnings than GRAIL. GRAIL is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilon Health$6.06B0.08-$260.15M-$0.77-1.47GRAIL$125.60M18.81-$2.03B-$13.11-5.00 Does the media refer more to AGL or GRAL? In the previous week, GRAIL had 10 more articles in the media than Agilon Health. MarketBeat recorded 12 mentions for GRAIL and 2 mentions for Agilon Health. GRAIL's average media sentiment score of 0.49 beat Agilon Health's score of -0.33 indicating that GRAIL is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GRAIL 3 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is AGL or GRAL more profitable? Agilon Health has a net margin of -5.35% compared to GRAIL's net margin of -329.86%. GRAIL's return on equity of -16.64% beat Agilon Health's return on equity.Company Net Margins Return on Equity Return on Assets Agilon Health-5.35% -66.76% -17.47% GRAIL -329.86%-16.64%-14.02% Which has more risk and volatility, AGL or GRAL? Agilon Health has a beta of 0.07, suggesting that its share price is 93% less volatile than the S&P 500. Comparatively, GRAIL has a beta of 4.11, suggesting that its share price is 311% more volatile than the S&P 500. SummaryAgilon Health beats GRAIL on 8 of the 14 factors compared between the two stocks. Get Agilon Health News Delivered to You Automatically Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGL vs. The Competition Export to ExcelMetricAgilon HealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$468.30M$8.23B$6.13B$21.82BDividend YieldN/A2.80%5.67%3.54%P/E Ratio-1.4775.2686.9629.82Price / Sales0.0840.93605.3267.55Price / CashN/A23.0137.9024.90Price / Book1.006.7612.554.60Net Income-$260.15M$250.93M$3.31B$1.00B7 Day Performance4.61%2.29%4.28%2.07%1 Month Performance-5.02%3.27%6.90%3.33%1 Year Performance-64.64%10.51%70.54%13.11% Agilon Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGLAgilon Health2.2436 of 5 stars$1.14+5.1%$3.08+171.1%-64.6%$468.30M$6.06B-1.471,076GRALGRAIL1.2217 of 5 stars$58.77+17.9%$31.50-46.4%+403.0%$1.80B$125.60M0.001,360News CoverageAnalyst ForecastInsider TradeGap UpHigh Trading VolumeVRDNViridian Therapeutics1.9625 of 5 stars$21.61+7.0%$34.88+61.4%-9.5%$1.65B$300K0.0050Positive NewsTDOCTeladoc Health1.6729 of 5 stars$8.22+0.7%$9.80+19.3%-0.4%$1.44B$2.57B-6.905,500News CoverageOMDAOmada HealthN/A$22.32-2.0%$24.50+9.8%N/A$1.31BN/A0.00849AHCOAdaptHealth3.9256 of 5 stars$8.68-2.4%$13.40+54.4%-12.9%$1.20B$3.26B17.1010,500News CoveragePositive NewsAnalyst UpgradePNTGThe Pennant Group4.073 of 5 stars$25.18-0.9%$34.40+36.6%-21.6%$877.88M$695.24M30.987,000News CoverageCDNACareDx4.371 of 5 stars$14.86-0.5%$25.50+71.6%-50.9%$794.68M$333.79M14.57740Analyst UpgradeFTREFortrea3.2742 of 5 stars$8.40-3.2%$11.50+36.9%-49.7%$788.14M$2.70B-0.7415,500Analyst ForecastFLGTFulgent Genetics3.505 of 5 stars$22.30-1.3%$25.33+13.6%+9.0%$691.46M$283.47M-13.431,313CSTLCastle Biosciences2.6202 of 5 stars$22.36-1.5%$37.00+65.5%-22.6%$658.78M$332.07M64.89540 Related Companies and Tools Related Companies GRAIL Alternatives Viridian Therapeutics Alternatives Teladoc Health Alternatives Omada Health Alternatives AdaptHealth Alternatives The Pennant Group Alternatives CareDx Alternatives Fortrea Alternatives Fulgent Genetics Alternatives Castle Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AGL) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agilon Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agilon Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
